Nexalin Technology (NXL) FCF Margin (2021 - 2026)
Nexalin Technology (NXL) posted FCF Margin of 14814.8% for Q2 2026, down 25.68% on a QoQ basis from 11787.72% in Q1 2026, and down 1351548.0% year-over-year from N/an in Q2 2025.
Powered by 
Analysis
Nexalin Technology (NXL) FCF Margin (2021 - 2026) Analysis & Trends
Nexalin Technology has reported FCF Margin for 6 years, with the latest figure at 14814.8% in Q2 2026.
- On a quarterly basis, FCF Margin fell 1351548.0% year-over-year to 14814.8% in Q2 2026; TTM through Jun 2026 was 2845.05%, a 39783.0% decrease from a year earlier, with the FY2025 full-year figure at 1643.53%, up 69429.0% from the prior year.
- FCF Margin was 14814.8% for Q2 2026 at Nexalin Technology, down from 11787.72% in the prior quarter.
- The five-year high for FCF Margin was 39.17% in Q2 2022, with the low at 14814.8% in Q2 2026.
- Average FCF Margin over 5 years is 3842.37%, with a median of 2633.31% recorded in 2023.
- The sharpest annual moves came in 2025 and 2026: FCF Margin soared 350623 bps in 2025, then plunged 1351548 bps in 2026.
- Over 5 years, FCF Margin stood at 2359.09% in 2022, then tumbled by 107 bps to 4889.12% in 2023, then grew by 15 bps to 4174.09% in 2024, then jumped by 84 bps to 667.86% in 2025, then sank by 2118 bps to 14814.8% in 2026.
- The last three FCF Margin figures came in at 14814.8% (Q2 2026), 11787.72% (Q1 2026), and 667.86% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 15.81% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 32.79% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 13.22% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 16.07% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 23.50% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 33.60% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 21.78% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 14.10% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.73% |
| 10 | Nexalin Technology | 3.44 Mn | 2.44 Mn | 8,897.00 | -14,814.80% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14,814.80% |
| Mar 31, 2026 | -11,787.72% |
| Dec 31, 2025 | -667.86% |
| Sep 30, 2025 | -8,079.00% |
| Jun 30, 2025 | -1,299.32% |
| Mar 31, 2025 | -3,477.30% |
| Dec 31, 2024 | -4,174.09% |
| Sep 30, 2024 | -2,220.89% |
| Jun 30, 2024 | -4,643.87% |
| Mar 31, 2024 | -970.23% |
| Dec 31, 2023 | -4,889.12% |
| Sep 30, 2023 | -2,907.54% |
| Jun 30, 2023 | -2,294.91% |
| Mar 31, 2023 | -4,301.86% |
| Dec 31, 2022 | -2,359.09% |
| Sep 30, 2022 | -173.05% |
| Jun 30, 2022 | -39.17% |
| Mar 31, 2022 | -62.87% |
| Dec 31, 2021 | -1,704.62% |